Avadel Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:AWK Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
21 Jan 25	Buy€38,102	Linda Palczuk	Individual	5,000	€7.62
13 Jan 25	Buy€78,873	Peter Thornton	Individual	10,000	€7.89
13 Jan 25	Buy€230,608	Eric Ende	Individual	30,000	€7.69
13 Dec 24	Buy€22,883	Thomas McHugh	Individual	2,300	€9.95
11 Dec 24	Buy€50,005	Thomas McHugh	Individual	5,000	€10.00
10 Dec 24	Buy€190,018	Geoffrey Glass	Individual	20,279	€9.41
09 Dec 24	Buy€94,243	Gregory Divis	Individual	10,000	€9.43
06 Dec 24	Buy€28,926	Linda Palczuk	Individual	3,000	€9.64

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of AWK?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	1,073,954	1.11%
General Public	4,157,535	4.3%
Hedge Funds	11,073,605	11.4%
Institutions	80,433,841	83.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 80.49% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
25.6%	Janus Henderson Group plc	24,717,664	€200.4m	-1.94%	0.09%
6.33%	Tontine Management, LLC	6,127,156	€49.7m	-3.21%	1.76%
5.86%	Brandes Investment Partners, LP	5,667,175	€45.9m	161%	0.3%
5.64%	BlackRock, Inc.	5,453,526	€44.2m	0.26%	no data
5.11%	Two Seas Capital LP	4,946,449	€40.1m	15.1%	6.23%
4.5%	Polar Capital Holdings Plc	4,355,964	€35.3m	-1.32%	0.14%
4.04%	The Vanguard Group, Inc.	3,904,650	€31.7m	-1.23%	no data
2.77%	Vivo Capital, LLC	2,684,109	€21.8m	0%	2.06%
2.45%	Wealth Effects LLC	2,369,122	€19.2m	1.07%	8.61%
2.32%	Citadel Advisors LLC	2,245,010	€18.2m	-13.4%	0.02%
2.17%	Tang Capital Management, LLC	2,097,500	€17.0m	40.1%	0.99%
1.72%	State Street Global Advisors, Inc.	1,659,306	€13.5m	-1.59%	no data
1.41%	UBS Asset Management AG	1,360,365	€11.0m	-15.4%	no data
1.23%	Geode Capital Management, LLC	1,189,596	€9.6m	2.09%	no data
1.13%	Bank of America Corporation, Asset Management Arm	1,089,341	€8.8m	1,890%	no data
1%	Samsara BioCapital LLC	967,527	€7.8m	0%	1.63%
0.98%	Krensavage Asset Management, LLC	950,000	€7.7m	0%	4.61%
0.97%	Medical Strategy GmbH, Asset Management Arm	938,161	€7.6m	0%	0.61%
0.93%	Woodline Partners LP	896,861	€7.3m	78.7%	0.05%
0.85%	SEB Investment Management AB	818,560	€6.6m	0%	0.01%
0.78%	Kennedy Capital Management LLC	754,043	€6.1m	-28.7%	0.16%
0.73%	Morgan Stanley, Investment Banking and Brokerage Investments	701,550	€5.7m	-15.8%	no data
0.7%	Neuberger Berman Investment Advisers LLC	676,632	€5.5m	39.8%	no data
0.67%	Goldman Sachs Group, Investment Banking and Securities Investments	652,200	€5.3m	-69%	no data
0.66%	Northern Trust Global Investments	639,866	€5.2m	-2.84%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/22 11:28
End of Day Share Price	2025/05/22 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Avadel Pharmaceuticals plc is covered by 17 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jason Butler	Citizens JMP Securities, LLC
Chase Knickerbocker	Craig-Hallum Capital Group LLC
Robin Garner Kalley	Craig-Hallum Capital Group LLC